According to a recent ArisGlobal poll, nineteen percent (19%) are worried about automation cost. Seventeen percent (17%) mentioned the replacement of human decision-making was a major concern. An additional 15% are focused on quality concerns.
- Cost associated with change 19% 19%
- Hesitancy to replace human decision-making 17% 17%
- Quality might suffer 15% 15%
- Organizational readiness to adopt this type of change 14% 14%
- Case volumes don’t justify the investment 12% 12%
- Lack of internal expertise 10% 10%
- Risk of change/perceived adverse impact to existing processes 8% 8%
- Unsure of the actual benefits of automation 3% 3%
- I don’t have any concerns about this 2% 2%
In this case study, the early adopter had multiple time-consuming manual activities for data reporting, capture, review and submission that resulted in low throughput, human error and compliance issues. Thanks to the adoption of automation through LSMV10, the customer was able to automate data extraction, review and reporting, ensuring accurate and consistent data capture and providing considerable savings. This example saw an efficiency gain of 35-40% in their case management process. As they expand automation capabilities, ArisGlobal’s time-motion studies suggest that efficiency gains of 50-55% can be achieved.
To learn more about the insights shared and questions answered, view on-demand webinar Automation in Pharmacovigilance: From Hype to Reality and to explore use cases, view on-demand webinar Key Use Cases of Automation in Pharmacovigilance held in June, 2019.
(This is Blog #3 in a series of 3 from Automation in Pharmacovigilance: From Hype to Reality webinar.)